What is PMV Pharmaceuticals Inc Annual Net Profit?

PMV Pharmaceuticals Inc Annual Net Profit rose 14.87% in the last year to $58.71 M. Its sector's average net profit growth for the last fiscal year was -17.35%.

What is PMV Pharmaceuticals Inc Price to Earning Ratio?

PMV Pharmaceuticals Inc Price to Earning Ratio is -0.96, which is negative.

What is PMV Pharmaceuticals Inc Stock Price?

PMV Pharmaceuticals Inc Stock Price fell 32.92% and underperformed its sector by 46.47% in the past year.

What is PMV Pharmaceuticals Inc Quarterly Net profit?

PMV Pharmaceuticals Inc Quarterly Net profit fell 45.98% YoY to $23 M. Its sector's average net profit growth YoY for the quarter was -51.46%.

What is PMV Pharmaceuticals Inc Debt to Equity Ratio?

PMV Pharmaceuticals Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is PMV Pharmaceuticals Inc Return on Equity(ROE)?

PMV Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -29.23%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is PMV Pharmaceuticals Inc Mutual Fund Holding?

PMV Pharmaceuticals Inc Mutual Fund Holding decreased by 0.01% in the last quarter to 17.18.

What is PMV Pharmaceuticals Inc Institutional Holding?

PMV Pharmaceuticals Inc Institutional Holding decreased by 0.2% in the last quarter to 76.46.

How is the PMV Pharmaceuticals Inc today?

The PMV Pharmaceuticals Inc today is trading in the down by -1.82% at 1.08.

How has PMV Pharmaceuticals Inc performed historically?

The PMV Pharmaceuticals Inc is currently trading down -1.82% on an intraday basis in the past week the index rose 13.68%. The index has been down -20.00% in the past quarter and fell -32.92% in the past year. You can view this in the overview section.

PMV Pharmaceuticals Inc XNAS: PMVP

PMV Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: PMV Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: PMV Pharmaceuticals Inc
Rating: 1.18258325
Author: Trendlyne DVM scores

Download real time

1.08 -0.02 (-1.82%)

52.21% Fall from 52W High

101.2K XNAS Volume

XNAS 22 Apr, 2025 5:30 PM (EDT)

PMV Pharmaceuticals Inc Key Metrics

My Metrics

Select

Market Capitalization Below industry Median Unavailable in chosen country	56.1
PE TTM Negative PE TTM Unavailable in chosen country	-1
PEG TTM Negative PEG TTM Unavailable in chosen country	-0.1
Price to Book Low in industry Unavailable in chosen country	0.3
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	76.5
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-46
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	14.9
Piotroski Score Low in industry Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	-16.6
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-29.2
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-26.5

All financials are in USD Million and price data in USD

Not Eligible

Expensive Valuation

15.3 / 100

Technically Bearish

32.0 / 100

No estimates available

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

PMV Pharmaceuticals Inc Stock Price Analysis

Day Price Range -1.8% 1 Day return Unavailable in chosen country	1.1 (LTP) 1.11.1 LowHigh
Week Price Range 13.7% 1 Week return Unavailable in chosen country	1.1 (LTP) 11.1 LowHigh
Month Price Range -15.0% 1 Month return Unavailable in chosen country	1.1 (LTP) 0.81.3 LowHigh
52 Week Price Range -32.9% 1 Year return Unavailable in chosen country	1.1 (LTP) 0.82.3 LowHigh

View full Share Price History

PMV Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

PMV Pharmaceuticals Inc Stock Analysis

PMV Pharmaceuticals Inc stock analysis with key metrics, changes, and trends.

PMV Pharmaceuticals Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Net Profit	$58.71 M	14.87%	positive	Annual Net Profit rose 14.87% in the last year to $58.71 M. Its sector's average net profit growth for the last fiscal year was -17.35%.
Price to Earning Ratio	-0.96	-	negative	Price to Earning Ratio is -0.96, which is negative.
Stock Price	$1.08	-32.92%	negative	Stock Price fell 32.92% and underperformed its sector by 46.47% in the past year.
Quarterly Net profit	$23 M	45.98%	negative	Quarterly Net profit fell 45.98% YoY to $23 M. Its sector's average net profit growth YoY for the quarter was -51.46%.
Debt to Equity Ratio	0.01	-	positive	Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-29.23 %	-29.23%	negative	Return on Equity(ROE) for the last financial year was -29.23%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	17.18 %	-0.01%	negative	Mutual Fund Holding decreased by 0.01% in the last quarter to 17.18.
Institutional Holding	76.46 %	-0.2%	negative	Institutional Holding decreased by 0.2% in the last quarter to 76.46.

VIEW LESS

Loading data..

PMV Pharmaceuticals Inc - Company Profile

What does PMV Pharmaceuticals Inc do?

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Gross Remuneration

2024

Gross Remuneration

Year

PMV Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

52.21% Fall from 52W High

PMV Pharmaceuticals Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

PMV Pharmaceuticals Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

PMV Pharmaceuticals Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

PMV Pharmaceuticals Inc Stock Analysis

PMV Pharmaceuticals Inc stock analysis with key metrics, changes, and trends.

Annual Net Profit rose 14.87% in the last year to $58.71 M. Its sector's average net profit growth for the last fiscal year was -17.35%.

Price to Earning Ratio is -0.96, which is negative.

Stock Price fell 32.92% and underperformed its sector by 46.47% in the past year.

Quarterly Net profit fell 45.98% YoY to $23 M. Its sector's average net profit growth YoY for the quarter was -51.46%.

Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -29.23%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 0.01% in the last quarter to 17.18.

Institutional Holding decreased by 0.2% in the last quarter to 76.46.

PMV Pharmaceuticals Inc - Company Profile

What does PMV Pharmaceuticals Inc do?

PMV Pharmaceuticals Inc Management structure

Mr. Robert Ticktin

General Counsel

Mr. Winston Kung, M.B.A.

Chief Operating Officer, Principal Accounting Officer and Chief Financial Officer

Dr. Leila Alland, M.D.

Chief Medical Officer

Dr. Deepika Jalota, Pharm.D.

Chief Development Officer

Mr. Michael Carulli

Chief Financial Officer and Principal Accounting Officer

Dr. Marc Fellous, M.D.

Senior Vice President and Head of Clinical Development and Medical Affairs

PMV Pharmaceuticals Inc Board of directors

Dr. Arnold J. Levine,PhD

Director

Dr. Carol G. Gallagher,Pharm.D.

Independent Director

Mr. David H. Mack, PhD

President, Chief Executive Officer and Director

Dr. Charles M. Baum, M.D.,PhD

Independent Director

Ms. Laurie D. Stelzer, M.B.A.

Independent Director

Ms. Kirsten Flowers

Independent Director

PMV Pharmaceuticals Inc FAQ

How is PMV Pharmaceuticals Inc today?

PMV Pharmaceuticals Inc today is trading in the red, and is down by -1.82% at 1.08.

How has PMV Pharmaceuticals Inc performed historically?

PMV Pharmaceuticals Inc is currently trading down -1.82% on an intraday basis. In the past week the stock rose 13.68%. stock has been down -20.00% in the past quarter and fell -32.92% in the past year. You can view this in the overview section.